Prime Medicine, Inc. (PRME) Total liabilities 2021–2025
Prime Medicine, Inc. (PRME) total liabilities at each fiscal year-end, per SEC filings.
$221.9MFY2025 · since FY2021: $62.3M → $221.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $221.9M | +53.7% |
| FY2024 | $144.4M | +137.5% |
| FY2023 | $60.8M | +38.0% |
| FY2022 | $44.0M | -29.3% |
| FY2021 | $62.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice